You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
衞信康(603676.SH):小兒多種維生素注射液(13)通過醫保談判納入國家醫保目錄
格隆匯 01-19 15:43

格隆匯1月19日丨衞信康(603676.SH)公佈,根據國家醫保局、人力資源社會保障部關於印發《國家基本醫療保險、工傷保險和生育保險藥品目錄(2022年)》的通知(醫保發〔2023〕5號),公司小兒多種維生素注射液(13)通過醫保談判納入《國家醫保目錄(2022年)》。

公司小兒多種維生素注射液(13)為含有13種維生素的複合維生素注射劑,適用於接受腸外營養的11週歲以下患者維生素缺乏的預防。小兒多種維生素注射液(13)為臨牀提供一種能符合醫學共識的小兒專用腸外維生素製劑,是公司基於患者需求進行差異化佈局的重點產品。經檢索,目前國內尚無其他企業生產該產品。

2021年,公司該產品銷售額為2965.1萬元,佔當期主營業務收入的2.87%;2022年前三季度,該產品銷售額為3528.88萬元,佔當期主營業務收入的3.31%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account